Quip Laboratories, Inc. (Quip Labs) is a Wilmington, Delaware-based manufacturer of disinfectants and cleaning chemicals, founded in 1985. The company specializes in biosafety and facility hygiene solutions, including EPA-registered chlorine dioxide products such as Quiptrol 3000 for water treatment, MB-10 and Vimoba tablets for disinfection, and related neutralizers.
It provides proprietary chemicals, equipment, environmental monitoring, decontamination services, training, and advisory support to achieve biological safety and sanitation in critical operations. Quip Labs serves industries including biomedical research, pharmaceutical production, life sciences, companion animal care, food processing, and healthcare.
Headquartered in a 30,000 sq. ft. facility with U.S. regional offices, the privately held company recently expanded through its affiliate Oxidium Technologies LLC, acquiring BASF's Aseptrol chlorine dioxide portfolio in March 2026 for applications in water purification and disinfection.
